HIGHLIGHTS
- who: Vincenzo Nasca from the Precision Biologics, Inc, United States University of Minnesota, United States have published the research work: Rechallenge of denosumab in advanced giant cell tumor of the bone after atypical femur fracture: A case report and review of literature, in the Journal: (JOURNAL)
- what: In Figure 4, the authors propose a brief clinical algorithm for the management of denosumab-related AFF.
SUMMARY
Giant cell tumor of the bone (GTCB) is a rare mesenchymal neoplasm, accounting for and amp;lt;5% of tumors directly arising from the bone. For . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.